| Giordanetto, Fabrizio (Taros Chemicals 201309– Director of Medicinal Chemistry before AstraZeneca + Pharmacia/Pfizer) |
Research & Development Manager |
Taros Chemicals GmbH & Co. KG |
Germany |
| Girling, Peter (CellnTec 201307 VP Stratetgic Development + Co-founder) |
Corporate Strategy Manager |
CellnTec Advanced Cell Systems AG |
Switzerland |
| Girod, Patrick (Herculis Partners 201702 Managing Partner) |
Managing Partner (investment firm) |
Herculis Partners S.A. |
|
| Girod, Pierre-Alain (Selexis 201610 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
JSR Corporation (Group) |
Switzerland |
| Giroud, Gérard (European Patent Office 200503) |
n. a. |
European Patent Organisation (EPO) |
Germany |
| Girsault, Hervé (Piqur Therapeutics 201306c– Business Development + Licensing Manager before Synosis + Novartis) |
Business Development Manager / Strategy Manager |
Piqur Therapeutics AG |
Switzerland |
| Girshik, Birgit (Charles River 201703 SVP Global Discovery) |
President/Director/Head Business Group/Unit/Division |
Charles River (Group) |
United States (USA) |
| Gitzinger, Marc (BioVersys 2008– CEO + Co-founder) |
Chief Executive Officer (CEO) |
BioVersys AG |
Switzerland |
| Giuliani, Germano (Board Member 202003 at ElevateBio + HBM + Royalty Pharma formerly CFO+CEO of Giulian SpA) |
Board member, non-executive |
ElevateBio (Group) |
United States (USA) |
| Giuliani, Giammaria (Gisev Family Office 202006 Co-Founder + Board Director at Cutiss AG) |
Company Founder |
Gisev (Family Office of Giammaria Giuliani) |
|
| Giuman, Marco (mk2 Biotechnologies 202107 Managing Director + Co-Founder) |
Managing Director |
mk2 Biotechnologies GmbH |
Germany |
| Giza, Helen (Fresenius 202212– CEO of Fresenius Medical Care joined 2019 as CFO before Takeda Pharma + TAP Pharma) |
Chief Executive Officer (CEO) |
Fresenius (Group) |
Germany |
| Gizler, Gerhard (Niedersachsen (govt) 200912 Managing Director NGlobal GmbH) |
Managing Director |
Niedersachsen (govt region) |
Germany |
| Gladsden, Brian (Mosaic Therapeutics 202304– CEO before Novartis + Bayer) |
Chief Executive Officer (CEO) |
Mosaic Therapeutics Ltd. |
United Kingdom (GB) |
| Gladwell, Mark (Qiagen 201710c– SVP Global Operations before Alere Inc) |
Board member, executive |
Qiagen (Group) |
Germany |
| Glanemann, Christoph (Trenzyme GmbH 201202 Lead Scientist + FPPM project manager) |
Researcher (industry) |
Trenzyme (Group) |
Germany |
| Glas, Adrian (Peptide Specialty Laboratories GmbH 201909 CEO) |
Chief Executive Officer (CEO) |
Peptide Specialty Laboratories GmbH |
Germany |
| Glass, Steve (BioMarin Europe 200801– VP + General Manager before Altana) |
Managing Director |
BioMarin (Group) |
United Kingdom (GB) |
| Gleba, Yurijus (Yuri) (Icon Genetics 200501 CEO) |
Chief Executive Officer (CEO) |
Denka (Group) |
Germany |
| Gleeson, Martin (Genalyte 201209 VP Development + Applications) |
n. a. |
Genalyte Inc. |
United States (USA) |
| Gleinser, Guido (Mediaire 202411 Chief Commcerical Officer) |
Chief Commercial Officer (CCO) |
Mediaire GmbH |
Germany |
| Glerup, Simon (Draupnir Bio 202106– CSO before CEO + Co-Founder) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Draupnir Bio ApS |
Denmark |
| Glick, Gary D. (Odyssey Therapeutics 202112 CEO + Co-Founder before Scorpion Therapeutics + IFM Therapeutics) |
Chief Executive Officer (CEO) |
Odyssey Therapeutics (Group) |
United States (USA) |
| Glieder, Anton (ACIB GmbH 201108 Managing Director) |
Managing Director |
ACIB GmbH – Austrian Centre of Industrial Biotechnology |
Austria |
| Glienke, Yvonne (MedicalMountains 202408 Managing Director) |
Managing Director |
MedicalMountains GmbH (formerly AG) |
Germany |
| Gligor, Mark (Helmholtz 201206 Biotechnologie Strategie BIO1 at Projektträger Jülich at FZ Jülich) |
n. a. |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Glinca, Serghei (CrystalsFirst 201709) |
n. a. |
CrystalsFirst GmbH |
Germany |
| Gline, Matthew (Matt) (Roivant 202102 CEO of Roivant Sciences) |
Chief Executive Officer (CEO) |
Roivant (Group) |
United States (USA) |
| Glinka, Jacek (Mylan 201312– President of European Business before Polpharma Group CEO) |
President/Director/Head Business Group/Unit/Division |
Viatris (Group) |
United States (USA) |
| Glombitza, Stefan (Formycon 202207– CEO joined 201610 as COO) |
Chief Executive Officer (CEO) |
Formycon (Group) |
Germany |
| Glund, Konrad (Probiodrug 1997–201804 Founder + CEO 2008 RETIRED 5/18) |
Chief Executive Officer (CEO) |
Vivoryon (Group) |
Germany |
| Glushik, John (Heritage Group 202308 Managing Director of HG Ventures) |
Managing Director |
Heritage Group (Group) |
United States (USA) |
| Glück, Tobias (Rentschler 202210– SVP Human Relations before Novartis Deutschland) |
Human Resources Manager |
Rentschler (Group) |
Germany |
| Gläser-Fischer, Kerstin (Thermo Fisher Scientific, D 200809) |
Sales Manager / Marketing Manager |
Thermo Fisher (Group) |
Germany |
| Glöckner, Frank Oliver (MPI Bremen + Jacobs Univ Bremen + Ribocon GmbH) |
Professor |
Max Planck Society for the Advancement of Science |
Germany |
| Glöggler, Klaus (DeklaTec GmbH 201110 Managing Director) |
Managing Director |
DeklaTec GmbH |
Germany |
| Glöggler, Sabine (Candor Bioscience 201310 Marketing + Communication) |
Sales Manager / Marketing Manager |
Candor Bioscience GmbH |
Germany |
| Gmuender, Marcel (Roche 201706 Global Head Diabetes Care) |
President/Director/Head Business Group/Unit/Division |
Roche (Group) |
Switzerland |
| Gnad-Vogt, Ulrike (CureVac 201710 CMO) |
Chief Medical Officer (CMO) |
CureVac (Group) |
Germany |
| Gnam, Christian (Bavaria (govt) 202404– Managing Director IZB before InsurTech Hub Munich + Invest in Bavaria) |
Managing Director |
Bavaria (govt region) |
Germany |
| Gockel, Peter (ChemCon GmbH 201209 Managing Director) |
Managing Director |
ChemCon GmbH |
Germany |
| Goddard, Colin (FoRx Therapeutics 202004– Executive Chairman former CEO of OSI Pharmaceuticals) |
Board member, executive |
FoRx Therapeutics AG |
Switzerland |
| Godde, Dirk (Digomed GmbH 201305 Managing Director) |
Managing Director |
Digomed: Medical IT – Solutions GmbH |
Germany |
| Godet, Franck (Wieland Capital 201811 Managing Partner before BNP Paribas + CSFB + DLJ + Paribas) |
Managing Partner (investment firm) |
Wieland Capital GmbH & Co. KG |
Germany |
| Godewerth, Thelse (Eppendorf 201801– VP Corp Human Resources + Organisational Development) |
n. a. |
Eppendorf (Group) |
Germany |
| Godfrey, Rebecca (ExpressionEdits 202405 COO) |
Chief Operating Officer (COO) |
ExpressionEdits Ltd. |
United Kingdom (GB) |
| Godl, Klaus (Kinaxo 200910 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Evotec (Group) |
Germany |
| Godula, Michal (Thermo Fisher 201304 Marketing Manager Food Safety and Environmental Applications) |
Sales Manager / Marketing Manager |
Thermo Fisher (Group) |
United States (USA) |
| Goebel, Frank (BRAIN 201703–201812c CFO joined 201502 before Royal Bank of Scotland WANTS TO LEAVE 8/18) |
Chief Financial Officer (CFO) |
BRAIN Biotech (Group) |
Germany |
| Goebel, Werner (Universität Würzburg 200504) |
n. a. |
University of Würzburg |
Germany |
| Goedesky, George (Bruker 201009 Exec Director Marketing + BusDev MALDI Biotyper) |
Sales Manager / Marketing Manager |
Bruker (Group) |
United States (USA) |
| Goergen, Bernd (High-Tech Gründerfonds 2007– Senior-Investmentmanager before DZ Bank 2000–2007) |
Investment Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
| Goerke, Andre (LenioBio 202407 CEO before Lonza) |
Chief Executive Officer (CEO) |
LenioBio GmbH |
Germany |
| Goetz, Wolfgang (Transcatheter Technologies 201105 CEO) |
Chief Executive Officer (CEO) |
Transcatheter Technologies GmbH |
Germany |
| Goff, Marcia (Thermo Fisher –201805 LEFT) |
n. a. |
Thermo Fisher (Group) |
United States (USA) |
| Goh, Wan Yee (Singapore (govt) 202401 SVP + Head of Healthcare at Singapore EDB) |
President/Director/Head Business Group/Unit/Division |
Singapore (govt) |
Singapore |
| Gohlke, Rüdiger (GSG Mess- und Analysengeräte 200803 Managing Director) |
Managing Director |
GSG Mess- und Analysengeräte GmbH |
Germany |
| Gohm, Harald (Tirol (govt) 201105 Standortagentur Tirol Managing Director) |
Managing Director |
Tirol (govt region) |
Austria |
| Goig, André (Syngenta 201306 Regional Director EAME + Chairman of EuropaBio since 201306) |
Regional manager |
Syngenta (Group) |
Switzerland |
| Goker, Hakan (Merck (DE) 201509 Senior Investment Direcotor MS Ventures before Aescap Venture + Atlas Venture) |
Investment Manager |
Merck (DE) (Group) |
Germany |
| Golaz, Louis (RED Horticulture 202311 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
RED Horticulture (Rouge Engineered Designs) (Group) |
France |
| Gold, Ludwig (Miracor 201407 CEO) |
Chief Executive Officer (CEO) |
Miracor (Group) |
Austria |
| Goldenbaum, Stephan (Solis BioDyne 202109– CEO before Eppendorf + Qiagen) |
Chief Executive Officer (CEO) |
Solis BioDyne OÜ |
Estonia |
| Goldenstein, Lissa (Auxogyn 201210 CEO) |
Chief Executive Officer (CEO) |
Auxogyn Inc. |
United States (USA) |
| Goldman, Jonathan (Abzena 202201 CEO formerly Aptuit CEO) |
Chief Executive Officer (CEO) |
Abzena (Group) |
United Kingdom (GB) |
| Goldman, Michel (Innovative Medicines Initiative 201103 Executive Director) |
President/Director/Head Business Group/Unit/Division |
Innovative Health Initiative (IHI JU) |
EU (European Union) |
| Goldschmidt, Colin (Sonic Healthcare 201701 CEO + Managing Director) |
Chief Executive Officer (CEO) |
Sonic Healthcare (Group) |
Australia |
| Goldsmith, George (Compass Pathways 202004 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Compass Pathways (Group) |
United Kingdom (GB) |
| Goldsmith, Neil (Sundew 202009 Chairman before Evolva –200910–201707 CEO STEPPED DOWN 7/17) |
Chief Executive Officer (CEO) |
Sundew ApS |
Denmark |
| Goletz, Steffen (Glycotope 201601– CSO before since 200809 Managing Director + Founder) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Glycotope (Group) |
Germany |
| Goll, Alexandra (TVM 200512) |
General Partner (venture partner) |
TVM (Group) |
Germany |
| Golla, Stephan (Univ of Western Sydney 201203) |
n. a. |
University of Western Sydney (UWS) |
Australia |
| Goller, Alexandra (MorphoSys 201803 Associate Director Corp Comm & IR) |
Public Relations Manager / Investor Relations Manager |
Novartis (Group) |
Germany |
| Golson, Russell (PreOmics 201712– CCO before Computomics + Biognosys + BioSilta + Febit + MWG Biotech) |
Chief Commercial Officer (CCO) |
Bruker (Group) |
Germany |
| Golumbeski, George (Celgene 201804 EVP + Executive Advisor for Innovation + proposed to MorphoSys Supervisory Board) |
President/Director/Head Business Group/Unit/Division |
Bristol Myers Squibb (BMS) (Group) |
United States (USA) |
| Gombert, Till (Protectimmun 200808 Founder) |
Company Founder |
Protectimmun GmbH |
Germany |
| Gonçalves, Dulce (Auven Therapeutics 201409– Corporate Counsel at ADC Therapeutics before Novartis) |
General Counsel / Chief Legal Officer (CLO) |
ADC Therapeutics (Group) |
Switzerland |
| Gonciarz, Grzegorz (Resistell 202007 COO) |
Chief Operating Officer (COO) |
Resistell AG |
Switzerland |
| Gonin, Marc (TOFwerk 202205 CEO + Co-Founder) |
Chief Financial Officer (CFO) |
TOFwerk AG |
Switzerland |
| Gonthiez, Thierry (Resolution Spectra Systems 202007 General Manager + Co-Founder) |
General Manager (management) |
Merck (DE) (Group) |
France |
| González, Juan-José (PolyPeptide 202304– CEO before Ambu A/S + JnJ + Pfizer + McKinsey + Procter & Gamble) |
Chief Executive Officer (CEO) |
PolyPeptide (Group) |
Switzerland |
| Gonzalez-Cadenas, Carlos (Index Ventures 202411 Partner) |
Partner (venture partner) |
Index Ventures |
United Kingdom (GB) |
| Gooch, Daniel (Scius Communciations 202109 formerly Instinctif Partners 201509) |
Public Relations Manager / Investor Relations Manager |
Scius Communications (GB) |
United Kingdom (GB) |
| Goodwin, Elizabeth (Galapagos 201112 Director Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Galapagos (Group) |
Belgium |
| Goorden, Bram (Sophia Genetics 202011– CCO + Head North America before Foundation Medicine + Prometheus Labs + Lilly) |
Chief Commercial Officer (CCO) |
Sophia Genetics (Group) |
United States (USA) |
| Gorbachev, Maxim (Russia (govt) 201501 Partner at RMI Partners) |
Partner (venture partner) |
Russia (govt) |
Russian Federation |
| Gordon, Carl L. (OrbiMed Advisors 201509 Partner) |
Partner (venture partner) |
OrbiMed (Group) |
United States (USA) |
| Gordon, Dale (Mirus Bio 202405 CEO) |
Chief Executive Officer (CEO) |
Roche (Group) |
United States (USA) |
| Gordon, Jenn (Global Health PR 201901) |
Public Relations Manager / Investor Relations Manager |
Global Health PR (US) |
United States (USA) |
| Gordon, Steven J. (Intelligent Bio-Systems 201206 CEO + founder) |
Chief Executive Officer (CEO) |
Qiagen (Group) |
United States (USA) |
| Goris, Ludwig (Capricorn Venture Partners 201808 Investment Manager) |
Investment Manager |
Capricorn Venture Partners (Group) |
Belgium |
| Gorman, Kevin (Neurocrine Biosciences 202005 CEO) |
Chief Executive Officer (CEO) |
Neurocrine Biosciences (Group) |
United States (USA) |
| Gorzka, Gabriele (Univ Kassel 201108 Head of OWWZ) |
President/Director/Head Business Group/Unit/Division |
University of Kassel |
Germany |
| Goschin, Jörg (Alstin GmbH 201108– Managing Director before Blackstone Group London + Cerberus Capital) |
Managing Director |
MASCHMEYER Group (family Maschmeyer) |
Germany |
| Gossé, Jörn (Körber 202407 CEO of Körber Pharma before 201905 CEO of Körber Medipak Systems) |
Chief Executive Officer (CEO) |
Körber (Group) |
Germany |
| Gotteland, Jean-Pierre (ObsEva 201701 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
ObsEva (Group) |
Switzerland |
| Gottraux, Jean-Claude (Roche 201404 Head of Roche Professional Diagnostics) |
President/Director/Head Business Group/Unit/Division |
Roche (Group) |
Switzerland |
| Gottschalk, Gerhard |
n. a. |
Project »Genomforschung an Mikroorganismen zur Analyse und Nutzung der Biodiversität« (Kompetenznetz, Uni Göttingen) |
Germany |
| Gottschalk, Uwe (Keensight Capital 202201– Operating Partner before Lonza + Sartorius + Bayer) |
Partner (venture partner) |
Keensight Capital SAS |
France |
| Gouliaev, Alex Haahr (Nuevolution 201205 CEO + Co-founder before NeuroSearch) |
Chief Executive Officer (CEO) |
Nuevolution (Group) |
Denmark |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 26 27 28 ... 93 94 95 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
